alls resulting in a head injury are common among older adults. 1,2 Advanced age and anticoagulation are thought to be associated with an increased risk of intracranial hemorrhage (ICH) after a head injury. [3][4][5] With the aging population and increasing use of anticoagulants, older patients on anticoagulation are commonly seen in the emergency department after a head injury. The Canadian CT Head Rule suggests that patients presenting to the emergency department with a minor head injury who are older than 65 years should undergo head imaging to rule out ICH. 6 This clinical decision tool did not include patients on anticoagulation; however, a clinical policy from the American College of Emergency Physician suggests computed tomography (CT) imaging for these patients. 7 Before 2010, warfarin, a vitamin K antagonist, was the oral anticoagulant used most commonly in North America. Since then, direct oral anticoagulants (DOACs) have been approved for various indications including treatment of venous thromboembolism, prevention of venous thromboembolism after arthroplasty, and stroke prophylaxis in patients with atrial fibrillation. Unlike warfarin, DOACs either directly inhibit clotting factors II (e.g., dabigatran) or X (e.g., apixaban, rivaroxaban, edoxaban). Although more expensive than warfarin, DOACs are attractive alternatives